506 related articles for article (PubMed ID: 21309771)
1. Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?
Andersen SL; Navalta CP
J Child Psychol Psychiatry; 2011 Apr; 52(4):476-503. PubMed ID: 21309771
[TBL] [Abstract][Full Text] [Related]
2. Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs.
Andersen SL; Navalta CP
Int J Dev Neurosci; 2004; 22(5-6):423-40. PubMed ID: 15380841
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological update in attention deficit hyperactivity disorder: models of intervention and new drugs].
Mulas F; Gandía R; Roca P; Etchepareborda MC; Abad L
Rev Neurol; 2012 May; 54 Suppl 3():S41-53. PubMed ID: 22605631
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder.
Biederman J; Spencer T
J Atten Disord; 2002; 6 Suppl 1():S101-7. PubMed ID: 12685524
[TBL] [Abstract][Full Text] [Related]
5. Management of psychopharmacologic agents in children and adolescents.
Carlson GA; Ranade L; Qadir A
Psychiatr Q; 1992; 63(4):391-411. PubMed ID: 1361998
[No Abstract] [Full Text] [Related]
6. Stimulants and the developing brain.
Andersen SL
Trends Pharmacol Sci; 2005 May; 26(5):237-43. PubMed ID: 15860370
[TBL] [Abstract][Full Text] [Related]
7. Postnatal brain development and psychotropic drugs. Effects on animals and animal models of depression and attention-deficit/hyperactivity disorder.
Bock N; Gerlach M; Rothenberger A
Curr Pharm Des; 2010; 16(22):2474-83. PubMed ID: 20513226
[TBL] [Abstract][Full Text] [Related]
8. [Adult attention deficit/hyperactivity disorder].
Laufkötter R; Eichhammer P; Hajak G
MMW Fortschr Med; 2004 Aug; 146(33-34):31-4. PubMed ID: 15526623
[TBL] [Abstract][Full Text] [Related]
9. Developmental neurobiology: implications for pediatric psychopharmacology.
Carrey N
Can J Psychiatry; 2001 Nov; 46(9):810-8. PubMed ID: 11761632
[TBL] [Abstract][Full Text] [Related]
10. A review of the use of psychotropic medication in pregnancy.
Galbally M; Snellen M; Lewis AJ
Curr Opin Obstet Gynecol; 2011 Dec; 23(6):408-14. PubMed ID: 21897237
[TBL] [Abstract][Full Text] [Related]
11. [Use of psychopharmaceuticals in children admitted to the Psychiatric Hospital for Children and Adolescents in Risskov in 1998].
Nissen JB; Thomsen PH
Ugeskr Laeger; 2003 Mar; 165(11):1137-41. PubMed ID: 12677992
[No Abstract] [Full Text] [Related]
12. Use, abuse, toxicity, and monitoring of pediatric psychotropic drug therapy: new issues for the new millennium.
Liebelt EL
Curr Opin Pediatr; 2002 Apr; 14(2):211-2. PubMed ID: 11981292
[No Abstract] [Full Text] [Related]
13. At long last, long-lasting psychiatric medications: an overview of controlled-release technologies.
Stahl SM
J Clin Psychiatry; 2003 Apr; 64(4):355-6. PubMed ID: 12716234
[No Abstract] [Full Text] [Related]
14. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
Winterstein AG; Soria-Saucedo R; Gerhard T; Correll CU; Olfson M
J Clin Psychiatry; 2017 Jul; 78(7):e744-e781. PubMed ID: 28686819
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy and the most common drugs for childhood psychiatric disorders].
Puustjärvi A; Raunio H; Lecklin A; Kumpulainen K
Duodecim; 2016; 132(10):943-50. PubMed ID: 27382830
[TBL] [Abstract][Full Text] [Related]
16. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
17. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
Correll CU; Kratochvil CJ; March JS
J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348
[TBL] [Abstract][Full Text] [Related]
18. Attention deficit/hyperactivity disorder across the lifespan.
Wilens TE; Biederman J; Spencer TJ
Annu Rev Med; 2002; 53():113-31. PubMed ID: 11818466
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of attention deficit hyperactivity disorder.
Spencer T; Biederman J; Wilens T
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
[TBL] [Abstract][Full Text] [Related]
20. Challenges and Promises of Pediatric Psychopharmacology.
Giles LL; Martini DR
Acad Pediatr; 2016 Aug; 16(6):508-18. PubMed ID: 27064142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
